Biomarker Concentrations at 1 Month After the Index 
Myocardial Infarction, myocardial injury
MYOCARDIAL INFARCTION, DYSFUNCTION, ACUTE CORONARY SYNDROME
The notion of a more favorable pathophysiological response in patients with MINOCA compared with MI‐CAD was supported by 1‐month biomarker concentrations and their changes from the acute phase of MI. More pronounced decreases for hs‐cTnT, NT‐proBNP, and hs‐CRP were noted in patients with MINOCA. At 1‐month follow‐up, concentrations of these biomarkers were lower both numerically and following adjustment. Taken together, this suggests less remaining myocardial injury, dysfunction, and inflammation/remodeling in the stable phase after MINOCA. However, as noticed both in the present study and in previous studies, GDF‐15 concentrations remain fairly constant from the acute to stable phase after acute coronary syndrome,Biomarker concentrations in the stable phase after an episode of MINOCA have only been investigated in the SMINC (Stockholm Myocardial Infarction With Normal Coronaries) study,